SE9500030D0 - Method of determining metastatic potential of tumor cells - Google Patents

Method of determining metastatic potential of tumor cells

Info

Publication number
SE9500030D0
SE9500030D0 SE9500030A SE9500030A SE9500030D0 SE 9500030 D0 SE9500030 D0 SE 9500030D0 SE 9500030 A SE9500030 A SE 9500030A SE 9500030 A SE9500030 A SE 9500030A SE 9500030 D0 SE9500030 D0 SE 9500030D0
Authority
SE
Sweden
Prior art keywords
cancer cells
tumors
malignant
human cancer
detection
Prior art date
Application number
SE9500030A
Other languages
English (en)
Other versions
SE504759C2 (sv
SE9500030L (sv
Inventor
Avraham Raz
Ivan R Nabi
Thomas Otto
Hideomi Watanbe
Original Assignee
Michigan Cancer Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michigan Cancer Foundation filed Critical Michigan Cancer Foundation
Publication of SE9500030D0 publication Critical patent/SE9500030D0/sv
Publication of SE9500030L publication Critical patent/SE9500030L/sv
Publication of SE504759C2 publication Critical patent/SE504759C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE9500030A 1992-07-14 1995-01-04 Förfarande för screening av urinblåsecancer och särskilt den metastatiska potentialen hos urinblåsecancerceller SE504759C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/913,107 US5382521A (en) 1992-07-14 1992-07-14 Method of determining metastatic potential of bladder tumor cells
PCT/US1993/006421 WO1994001777A1 (en) 1992-07-14 1993-07-08 Method of determining metastatic potential of tumor cells

Publications (3)

Publication Number Publication Date
SE9500030D0 true SE9500030D0 (sv) 1995-01-04
SE9500030L SE9500030L (sv) 1995-03-10
SE504759C2 SE504759C2 (sv) 1997-04-21

Family

ID=25432932

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9500030A SE504759C2 (sv) 1992-07-14 1995-01-04 Förfarande för screening av urinblåsecancer och särskilt den metastatiska potentialen hos urinblåsecancerceller

Country Status (7)

Country Link
US (3) US5382521A (sv)
EP (1) EP0656114A4 (sv)
JP (1) JPH08501929A (sv)
AU (1) AU672808B2 (sv)
CA (1) CA2139500A1 (sv)
SE (1) SE504759C2 (sv)
WO (1) WO1994001777A1 (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449753A (en) * 1992-01-17 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Autotaxin: motility stimulating protein useful in cancer diagnosis
ATE247176T1 (de) * 1994-12-29 2003-08-15 Eiken Chemical Verfahren zur zellerkennung
WO1996039504A2 (en) * 1995-06-06 1996-12-12 Novartis Ag Methods for distinguishing metastatic and non-metastatic cancers, polynucleotides and polypeptides for use therein
DE19818619A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Tumor
CA2238257A1 (en) * 1998-05-22 1999-11-22 Universite De Montreal Endocytosis of amf-r and uses thereof in cancer therapy
US7226731B1 (en) 1998-07-24 2007-06-05 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services PB 39, a gene dysregulated in prostate cancer, and uses thereof
EP1100903A1 (en) * 1998-07-24 2001-05-23 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Pb 39, a gene dysregulated in prostate cancer, and uses thereof
KR100837341B1 (ko) 2006-11-10 2008-06-12 경북대학교 산학협력단 방광암 표적용 펩타이드 및 이의 용도
EP3689250B1 (en) 2011-10-17 2022-12-07 BFLY Operations, Inc. Transmissive imaging and related apparatus and methods
US9667889B2 (en) 2013-04-03 2017-05-30 Butterfly Network, Inc. Portable electronic devices with integrated imaging capabilities
WO2018005378A1 (en) * 2016-06-28 2018-01-04 Kun-Chih Tsai Method for detecting and isolating invasive cancer stem cells employing cell-surface amfr and the use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2851288B2 (ja) * 1987-06-05 1999-01-27 アメリカ合衆国 癌診断および管理における自己分泌運動性因子

Also Published As

Publication number Publication date
WO1994001777A1 (en) 1994-01-20
US5382521A (en) 1995-01-17
US5541298A (en) 1996-07-30
SE504759C2 (sv) 1997-04-21
EP0656114A4 (en) 1998-07-08
AU672808B2 (en) 1996-10-17
AU4668293A (en) 1994-01-31
SE9500030L (sv) 1995-03-10
CA2139500A1 (en) 1994-01-20
JPH08501929A (ja) 1996-03-05
EP0656114A1 (en) 1995-06-07
US5650500A (en) 1997-07-22

Similar Documents

Publication Publication Date Title
TR200200937T2 (tr) Yumurtalık kanseri tedavisi için bileşimler.
ATE130873T1 (de) Nachweis der expression von neu genen und produkten.
ATE433498T1 (de) Detektion von neoplasien durch speichelanalyse
DK1064303T3 (da) Monoklonale antistoffer, der er specifikke for det prostataspecifikke membranantigens ekstracellulære domæne
ATE198513T1 (de) Ptpalpha-bestimmung in der tumordiagnose und - prognose
TR200101482T2 (tr) WT1'e özgü imünoterapi için bileşimler
CA2164498A1 (en) Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
DE69735294D1 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
SE9500030D0 (sv) Method of determining metastatic potential of tumor cells
FI963393A0 (sv) Bestämning av cancerförhållanden med hjälp av MAGE-gen-expression
DK1007537T3 (da) Receptor-protein med betegnelsen 2F1
EP2366712A3 (en) A tumor suppressor designated TS10Q23.3
DE59208916D1 (de) Verfahren zum nachweis der differenzierung und der invasivität von karzinomzellen
Hatta et al. Polymerase chain reaction and immunohistochemistry frequently detect occult melanoma cells in regional lymph nodes of melanoma patients.
AU9120398A (en) A tumor suppressor designated ts10q23.3
ES2164634T3 (es) Produccion y uso de proteina nm23-h2 humana y anticuerpos previstos a tal efecto.
ES8802196A1 (es) Metodo para determinar la presion de un estado maligno en tejidos.
WO1999006831A3 (en) Breast cancer resistance genes, methods for their detection and uses thereof
DE69725297D1 (de) Immuno-magnetische zelltrennung zur erkennung von krebsmetastasenbildung-assozierten genen
CA1108988A (en) Viral related protein assay for detection of cancer
DE69735676D1 (de) Proteinmarker für ösophaguskrebs
ATE98685T1 (de) Metastasenzugehoerige kollagenolytische metalloproteinase.
BR0012301A (pt) Inibidores de crescimento de células epiteliais
IL151687A0 (en) G-protein coupled receptors
ATE521623T1 (de) Neues, bei prostatakrebs exprimiertes gen und verwendungsverfahren

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9500030-3

Format of ref document f/p: F